Overactive Bladder - Results from #960

Overactive Bladder is a Distress Symptom in Heart Failure July 17, 2018

Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer July 17, 2018

Involvement of calcium regulating ion channels in contractility of human isolated urinary bladder July 1, 2018

The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study July 1, 2018

Association of uterine leiomyoma and overactive bladder syndrome. July 1, 2018

Impact of serum 25-OH vitamin D level on lower urinary tract symptoms in men: a step towards reducing overactive bladder July 1, 2018

What Is New in Neuromodulation for Overactive Bladder? May 29, 2018

Metabolomic Analysis of Overactive Bladder in Male Patients: Identification of Potential Metabolite Biomarkers May 29, 2018

A prospective, non-intErventional registry study of PatiEnts initiating a course of drug therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology May 28, 2018

Women undergoing third line overactive bladder treatment demonstrate elevated thermal temporal summation May 15, 2018

Review of Economic Value Drivers of the Treatment of Overactive Bladder May 15, 2018

Treatment of Non-neurogenic Overactive Bladder with OnabotulinumtoxinA: Systematic Review and Meta-analysis of Prospective, Randomized, Placebo-controlled Clinical Trials May 12, 2018

Transcutaneous tibial nerve stimulation: 2 years follow-up outcomes in the management of anticholinergic refractory overactive bladder. May 7, 2018

Mirabegron 25 Mg Monotherapy is Safe but Less Effective in Male Overactive Bladder Patients with Bladder Outlet Obstruction May 7, 2018

Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects May 7, 2018

Basic and clinical aspects of Antimuscarinic agents used to treat overactive bladder May 6, 2018

Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada May 4, 2018

Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis May 1, 2018

Efficacy and safety of mirabegron, a β3 -adrenoceptor agonist, in patients with detrusor hyperactivity and impaired contractility. May 1, 2018

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK May 1, 2018

Page 49 of 122